Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCAT autologous stem cells in Achilles tendinopathy
2013-000966-12Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in Achilles tendinitis (AT), sponsored by University College London. Primary endpoint: Incidence rate of serious adverse reactions. Started Jan 2019; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
Achilles tendinitis (AT)
Beyond the preview
Go deeper on 2013-000966-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000966-12.